The Orthopedic Software Market Size was assessed at USD 392.74 million in 2023, and is predicted to increase at a CAGR of 8.1 percent from 2024 to 2031, to reach USD 732.35 million.
Orthopedic software allows orthopedic physicians and surgeons to improve the way they keep track of treatment processes and clinical data while saving time. This software aids surgeons during surgery and assists in the maintenance of electronic health records (EHR).
Get more information on Orthopedic Software Market - Request Sample Report
The increase in the incidence of arthritis due to the growing number of the elderly, the growing pressure to improve quality of care and reduce the cost of health care, increased EHR adoption and other eHealth solutions, and the growing demand for slower therapies all drive the market. forward. However, doubts among orthopedic surgeons to use orthopedic software due to privacy and data security, lack of trained and competent resources, the need for large infrastructure investments, and the high cost of distributing software solutions are expected to reduce market growth during forecasting time.
DRIVERS
The expanding senior population is leading to an increase in the incidence of orthopedic problems.
Increasing demand to enhance healthcare quality and cut costs
EHRs and other eHealth technologies are becoming more widely used.
The desire for minimally invasive treatments is increasing.
RESTRAINTS
There is a reluctance among orthopaedic surgeons to employ orthopaedic software because of privacy and data security issues.
There is a scarcity of qualified and skilled personnel.
Infrastructure investments are large, and deployment costs are considerable.
OPPORTUNITIES
The application of orthopaedic software in mobile platforms and the availability of orthopaedic software as cloud-based solutions
Shift in healthcare delivery to be more patient-centered
CHALLENGES
Integrity and interoperability are lacking.
Due to mergers between healthcare organisations, technology is being consolidated.
Lack of awareness causes a hesitancy to accept innovative solutions.
The covid-19 epidemic wreaked havoc on worldwide markets, particularly the orthopedic software market. The orthopedic and musculoskeletal departments, like other healthcare departments, have accelerated their use of virtual care delivery methods, boosting the worldwide orthopedic software market's growth. The government's relaxation and improvement of some guidelines, in particular, has facilitated the rapid adoption of these technologies. In recent years, the worldwide orthopedic software industry has had excellent growth outcomes due to the rapid adoption of payment models to improve virtual patient care, particularly during pandemic periods. As a result, while the pandemic interrupted the worldwide orthopedic software business, it also provided a significant boost to the sector.
By Type of Product
Orthopedic digital templating/preoperative planning software, orthopedic electronic health records (EHRs), orthopedic practice management (PM), orthopedic picture archiving and communication systems (PACS), and orthopedic revenue cycle management are the different segments of the orthopedic software market (RCM). The segment of the worldwide orthopedic software market that deals with picture archiving and communication systems (PACS). The accessibility of muscular PACS that is associated with advanced templating programming is driving the interest for muscular PACS since it permits specialists to productively do computerized templating more. This shifts the emphasis away from time-consuming surgical procedures. It also cuts down on the additional expenditures associated with equipment sterilization.
By Mode of Delivery
On-premise and cloud-based orthopedic software options are available. The market for orthopedic software was dominated by on-premise options. This is due to on-premise systems' increased control and security of patient data.
By Application
Joint replacement, fracture management, pediatric assessment, and other applications are the four key categories of orthopedic software. The joint replacement market held the greatest share of the whole market. During the forecast period, this segment likewise had the highest CAGR. The expanded commonness of constant illnesses has brought about an expansion in the quantity of joint tasks performed and, thus, the quantity of amendment methods performed, which is impelling the market forward. Non-crisis medical procedures have been shoved aside because of the effect of COVID-19. In the next months, this is projected to lower demand for orthopedic surgical instruments.
By End Users
Hospitals, ambulatory care centres, and other end users are divided into the orthopaedic software market. The market for orthopaedic software is dominated by the healthcare sector. The advent of the COVID-19 pandemic, as well as the necessity for patient data for PHM, has fueled strong demand for orthopaedic software among hospitals.
By Type of Product
Orthopedic Picture Archiving and Communication Systems (PACS)
Digital templating/Pre-operative Planning software
Orthopedic Electronic health records
Orthopedic Revenue Cycle Management (RCM)
Orthopedic Practice management
By Mode of Delivery
On-premises software
Cloud-based software
By Application
Joint Replacement
Pediatric Assessment
Fracture Management
By End Users
Hospitals
Ambulatory Care centers
North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are the five key regions that make up the orthopedic software market. During the predicted period, North America held the greatest market share. The muscular programming market in North America is creating because of variables, for example, expanded reception of electronic wellbeing records (EHRs), government endeavors to further develop the medical services framework, and a rising number of flow research projects.
During the projected period, however, the Asia Pacific region is expected to increase the most. The orthopedic market in this region will expand as a result of lower penetration of orthopedic software, the need to strengthen healthcare infrastructures, and the growing demand to reduce healthcare expenses.
Need any customization research on Orthopedic Software Market - Enquiry Now
REGIONAL COVERAGE:
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Rest of Europe
Asia-Pacific
Japan
south Korea
China
India
Australia
Rest of Asia-Pacific
The Middle East & Africa
Israel
UAE
South Africa
Rest of Middle East & Africa
Latin America
Brazil
Argentina
Rest of Latin America
Some of the major key players are as follows: Medstrat, Inc., Brainlab AG, Materialise NV, Greenway Health, CureMD Healthcare, Merge Healthcare Incorporated, NextGen Healthcare LLC, Philips Healthcare, GE Healthcare, and McKesson Corporation and Other Players.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | US$ 392.74 Million |
| Market Size by 2031 | US$ 732.35 Million |
| CAGR | CAGR of 8.1% From 2024 to 2031 |
| Base Year | 2023 |
| Forecast Period | 2024-2031 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type of Product (Orthopedic Picture Archiving and Communication Systems (PACS), Digital templating/Pre-operative Planning software, Orthopedic Electronic health records, Orthopedic revenue cycle management (RCM), Orthopedic Practice management) • By Mode of Delivery (On-premises software, Cloud-based software) • By Application (Joint Replacement, Pediatric Assessment, Fracture Management) • By End Users (Hospitals, Ambulatory Care centers) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Medstrat, Inc., Brainlab AG, Materialise NV, Greenway Health, CureMD Healthcare, Merge Healthcare Incorporated, NextGen Healthcare LLC, Philips Healthcare, GE Healthcare, and McKesson Corporation. |
| DRIVERS | • The expanding senior population is leading to an increase in the incidence of orthopedic problems. • Increasing demand to enhance healthcare quality and cut costs • EHRs and other eHealth technologies are becoming more widely used. |
| RESTRAINTS | • There is a reluctance among orthopaedic surgeons to employ orthopaedic software because of privacy and data security issues. • There is a scarcity of qualified and skilled personnel. • Infrastructure investments are large, and deployment costs are considerable. |
Ans: The Orthopedic Software Market size was valued at US$ 392.74 Mn in 2023.
Ans: The Orthopedic Software Market is to grow at a CAGR of 8.1% over the forecast period 2024-2031.
North America held the greatest market share.
Increasing demand to enhance healthcare quality and cut costs, EHRs and other eHealth technologies are becoming more widely used. are drivers of Orthopedic Software market.
There is a scarcity of qualified and skilled personnel, Infrastructure investments are large, and deployment costs are considerable is the main restraints of the Orthopedic Software market.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 COVID-19 Impact Analysis
4.2 Impact of Ukraine- Russia War
4.3 Impact of Ongoing Recession
4.3.1 Introduction
4.3.2 Impact on major economies
4.3.2.1 US
4.3.2.2 Canada
4.3.2.3 Germany
4.3.2.4 France
4.3.2.5 United Kingdom
4.3.2.6 China
4.3.2.7 Japan
4.3.2.8 South Korea
4.3.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Orthopedic Software Market Segmentation, By Type of Product
8.1 Orthopedic Picture Archiving and Communication Systems (PACS)
8.2 Digital templating/Pre-operative Planning software
8.3 Orthopedic Electronic health records
8.4 Orthopedic Revenue Cycle Management (RCM)
8.5 Orthopedic Practice Management
9. Orthopedic Software Market Segmentation, By Mode of Delivery
9.1 On-premises software
9.2 Cloud-based software
10. Orthopedic Software Market Segmentation, By Application
10.1 Joint Replacement
10.2 Pediatric Assessment
10.3 Fracture Management
11. Orthopedic Software Market Segmentation, By End Users
11.1 Hospitals
11.2 Ambulatory Care Centers
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 USA
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 France
12.3.4 Italy
12.3.5 Spain
12.3.6 The Netherlands
12.3.7 Rest of Europe
12.4 Asia-Pacific
12.4.1 Japan
12.4.2 South Korea
12.4.3 China
12.4.4 India
12.4.5 Australia
12.4.6 Rest of Asia-Pacific
12.5 The Middle East & Africa
12.5.1 Israel
12.5.2 UAE
12.5.3 South Africa
12.5.4 Rest
12.6 Latin America
12.6.1 Brazil
12.6.2 Argentina
12.6.3 Rest of Latin America
13. Company Profiles
13.1 Medstrat, Inc.
13.1.1 Financial
13.1.2 Products/ Services Offered
13.1.3 SWOT Analysis
13.1.4 The SNS view
13.2 Brainlab AG
13.3 Materialise NV
13.4 Greenway Health
13.5 CureMD Healthcare
13.6 Merge Healthcare Incorporated
13.7 NextGen Healthcare LLC
13.8 Philips Healthcare
13.9 GE Healthcare
13.10 McKesson Corporation.
14. Competitive Landscape
14.1 Competitive Benchmark
14.2 Market Share Analysis
14.3 Recent Developments
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The global Upstream Bioprocessing market, valued at USD 24.20 Billion in 2023, is projected to reach USD 81.15 Billion by 2032, growing at a compound annual growth rate CAGR of 15.22% during the forecast period.
The Injectable Cytotoxic Drugs Market size was USD 19.58 Billion in 2023 and is expected to Reach USD 38.15 Billion by 2032 and grow at a CAGR of 6.9% over the forecast period of 2024-2032.
The Bioinformatics Market Size was valued at USD 11.58 billion in 2023 and will reach USD 34.69billion by 2031 and grow at a CAGR of 14.7% by 2024-2031.
The Assisted Reproductive Technology (ART) Market is expected to reach USD 45.75 Bn by 2032 and was valued at USD 27.13 Bn in 2023 the CAGR growth rate will be 5.98% over the forecast period of 2024-2032.
The Microplate Reader Market size was estimated at USD 486.89 million in 2023 and is expected to reach USD 941.32 million by 2032 at a CAGR of 7.6% during the forecast period of 2024-2032.
The Urinary Drainage Bags Market size was valued at USD 2.12 billion in 2023 and will reach USD 3.13 billion by 2031 & growing at a CAGR of 5% by 2024-2031.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
